5+ ITEMS = 10% OFF
EU WAREHOUSE · 24–48H DELIVERY
PLAIN BOX · ZERO BRANDING
PAY THE COURIER · NO CARD NEEDED
FREE SHIPPING OVER €85
5+ ITEMS = 10% OFF
EU WAREHOUSE · 24–48H DELIVERY
PLAIN BOX · ZERO BRANDING
PAY THE COURIER · NO CARD NEEDED
FREE SHIPPING OVER €85
Try a substance, brand, or product name…
Cart 0
€85,00 more for free shipping
No products in the cart.
Injectable Steroids
Tri-Trenabol 150mg (Trenbolone Blend)
Tri-Trenabol 150mg (Trenbolone Blend) (150 mg) — Trenbolone Enanthate combines the unmatched anabolic power of Trenbolone with the dosing convenience of a long-acting enanthate es...
€65,00
In Stock(100 available)
Medical Pharma · Tri-Trenabol 150mg (Trenbolone Blend) (150 mg) — Trenbolone Enanthate combines the unmatched anabolic power of Trenbolone with the dosing convenience of a long-acting enanthate es…
100 in stock
5+−10%
10+−15%Best price
Third-Party Lab ReportHPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
Trenbolone Enanthate, the manufacturer, 150 mg. Week-long ester version of trenbolone’s extraordinary receptor activation. Better suited to experienced users who already know their tren tolerance — longer clearance means slower side-effect resolution.
Active molecule identical to single-ester tren at AR level
Same side-effect burden as standalone tren — blend isn’t softer
Each unit dosed at 150 mg — see Recommended Dosage below for protocol-specific intake
Recommended Dosage
Research dosing: 150–300 mg/week split across 2–3 injections. The acetate fraction peaks within a day while longer esters build steady-state over 3–4 weeks. Cycles 10–12 weeks.
How It Works
Blend of trenbolone acetate, enanthate, and hexahydrobenzylcarbonate (parabolan) — all three are 19-nor derivatives with the same extreme AR affinity as single-ester trenbolone. Progestagenic. The blend provides staggered release: acetate in ~24 h, enanthate ~7 days, hexa ~10 days. At the receptor level the active molecule is identical across esters.
Pharmacokinetics
Composite release profile. Faster kick-in than pure enanthate, flatter serum than pure acetate. Injection frequency every 3–4 days adequate. Steady-state in 3–4 weeks.
Potential Side Effects
Identical to single-ester tren: prolactin rise, night sweats, insomnia, CV stress, aggression. Caber 0.25 mg 2×/week mandatory. Bloodwork including prolactin at week 6.
Cycle & Stacking Guide
Cutting and recomp cycles 10–12 weeks. Test E 300–500 mg/week + tren blend 200–300 mg/week. Attention to sleep, resting HR, and lipids throughout. Not for first or second cycles.
Storage & Handling
Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.
Mechanism & protocol-relevant pharmacology, reviewed by editorial pharmacology lead
19-nor 5alpha-reduced analogue of nandrolone. Non-aromatizable — AR-binding affinity roughly 5x testosterone, with measurable agonist activity at the progesterone receptor. The acetate ester generates fast serum peaks and drops; EOD administration is the floor for stable concentrations. Clinical picture: rapid lean-tissue accretion independent of caloric surplus, reduced adipose mass via direct AR signalling in adipocytes, pronounced lipid shift (HDL suppression 40–60%). Prolactin elevation occurs in a subset — cabergoline 0.25 mg twice weekly is the standard response. Renal biomarkers (creatinine, cystatin C) commonly shift upward; this reflects haem metabolite excretion in urine (brick-red pigment) rather than confirmed nephrotoxicity, but CKD-EPI readings should be interpreted with the confounding documented. Nocturnal sympathetic tone (insomnia, diaphoresis) is dose-dependent and resolves on cessation.
Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.
Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.
We use cookies for essential site functionality and — with your consent — for analytics and marketing. You can accept all, reject non-essential, or configure. Privacy Policy
Reviews
There are no reviews yet.